CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Changzhou Qianhong Biopharma Co., Ltd. Company Snapshot
Changzhou Qianhong Biopharma Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Changzhou Qianhong Biopharma Co., Ltd. with three other companies in this sector in China: Zhejiang Yatai Pharmaceutical Co.,Limited (2017 sales of 1.08 billion Chinese Renmimbi [US$158.14 million] of which 57% was CRO Service), Tianjin Lisheng Pharmaceutical Company Limited (1.03 billion Chinese Renmimbi [US$150.33 million] of which 100% was Phamaceutical Manufacturing), and Anhui Anke Biotechnology (Group) Company., Limited (1.10 billion Chinese Renmimbi [US$160.09 million] of which 58% was Biological Products).

Sales Analysis. During the year ended December of 2017, sales at Changzhou Qianhong Biopharma Co., Ltd. were 1.07 billion Chinese Renmimbi (US$155.59 million). This is an increase of 37.2% versus 2016, when the company's sales were 776.38 million Chinese Renmimbi. Sales of Bio-Pharmaceutical Industry saw an increase of 37.3% in 2017, from 775.85 million Chinese Renmimbi to 1.07 billion Chinese Renmimbi. Not all segments of Changzhou Qianhong Biopharma Co., Ltd. experienced an increase in sales in 2017: sales of Other Operations fell 90.6% to 50,326.31 Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Changzhou Qianhong Biopharma Co., Ltd.
  Stock Performance Chart for Changzhou Qianhong Biopharma Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (9/21/2018): 4.81
(Figures in Chinese Renmimbi)
1 Week 1.7%   13 Weeks 4.3%  
4 Weeks -13.0%   52 Weeks -21.5%  
 
Changzhou Qianhong Biopharma Co., Ltd. Key Data:
  Ticker: 002550 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,065,466,102
(Year Ending Jan 2018).
Employees: 1,164
  Currency: Chinese Renmimbi Market Cap: 6,127,560,972
  Fiscal Yr Ends: December Shares Outstanding: 1,273,921,200
  Share Type: Gu A Closely Held Shares: 529,354,613
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.